glp 1 and gip receptor agonist Not all GLP-1–based therapies work the same way. Semaglutide targets the -1 receptor, while tirzepatide targets both GLP-1 receptors. Retatrutide is being studied as a triple-receptor targeting GLP-1, GIP curb cravings Medication:Tirzepatide (GLP-1 + GIP) Therapeutic Potential of GLP-1

glp 1 and gip receptor agonist Not all GLP-1–based therapies work the same way. Semaglutide targets the -1 receptor, while tirzepatide targets both GLP-1 receptors. Retatrutide is being studied as a triple-receptor targeting GLP-1, GIP curb cravings Medication:Tirzepatide (GLP-1 + GIP) Therapeutic Potential of GLP-1

Therapeutic Potential of GLP-1 Receptor Agonists in Diabetes and Cardiovascular Disease: Mechanisms and Clinical Implications | Cardiovascular Drugs and Therapy | Springer Nature Link

Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice

curb cravings

Medication:Tirzepatide (GLP-1 + GIP)

Diabetologia (1986) 29:46–52